Jonathan Will McGuire - 20 Nov 2022 Form 4 Insider Report for Ra Medical Systems, Inc. (VTAK)

Reporting relationship: CEO & Secretary, Director
Issuer ticker: VTAK
Reported as of: 20 Nov 2022
Net transaction value: -$224
SEC form: 4
Accepted by SEC: 15 Mar 2023, 16:11:51 UTC
Prior SEC filing: 24 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Will McGuire

Key filing fact

Jonathan Will McGuire filed Form 4 for Ra Medical Systems, Inc. (VTAK) on 15 Mar 2023.

Key facts

This page summarizes Jonathan Will McGuire's Form 4 filing for Ra Medical Systems, Inc. (VTAK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Mar 2023, 16:11.

Change

Previous filing in this sequence was filed on 24 May 2022.
Current net transaction value: -$224.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMED transaction

Common Stock

Tax liability

Transaction value: $224
Shares: -84
Change %: -7.2%
Price: $2.67^*
Shares after: 1,083
Date: 20 Nov 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities.

Footnote F2

Reflects shares as a result of a reverse stock split.